Lidds AB (Sweden) Insiders
| LIDDS Stock | SEK 0.16 0.01 5.88% |
Lidds AB employs about 7 people. The company is managed by 22 executives with a total tenure of roughly 123 years, averaging almost 5.0 years of service per executive, having 0.32 employees per reported executive. Breaking down Lidds AB's management performance can provide insight into the firm performance.
| Jan Tornell Chairman Chairman of the Board |
Lidds |
Lidds AB Management Team Effectiveness
The company has return on total asset (ROA) of (0.4569) % which means that it has lost $0.4569 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8878) %, meaning that it generated substantial loss on money invested by shareholders. Lidds AB's management efficiency ratios could be used to measure how well Lidds AB manages its routine affairs as well as how well it operates its assets and liabilities.Lidds AB Workforce Comparison
Lidds AB is currently regarded as number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 429,676. Lidds AB adds roughly 7.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Lidds AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Lidds AB Price Series Summation is a cross summation of Lidds AB price series and its benchmark/peer.
Lidds AB Notable Stakeholders
A Lidds AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lidds AB often face trade-offs trying to please all of them. Lidds AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lidds AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jan Tornell | Chairman of the Board | Profile | |
| Bengt Norvik | CFO | Profile | |
| IngaLill Forslund | Director | Profile | |
| Susanna Urdmark | Director | Profile | |
| Ingalill Larsson | Director | Profile | |
| Maria Forss | Director | Profile | |
| Daniel Lifveredson | Director | Profile | |
| Anders Bjartell | Director | Profile | |
| David Bejker | Director | Profile | |
| CarlGustaf Golander | Head of Clinical Research & Development | Profile | |
| Charlotta Gauffin | Head of Clinical Development | Profile | |
| Jenni Bjornulfson | CFO IR | Profile | |
| Kia Bengtsson | Head Devel | Profile | |
| Matthew Lindon | Chief Officer | Profile | |
| Stefan Gruden | Head of Pharmaceutical FoU | Profile | |
| Annette Moldrup | Chief Officer | Profile | |
| Johan MD | Chief Officer | Profile | |
| Anna Torner | Head of Regulatory Strategy and Plan | Profile | |
| Niklas Axen | Head of Material & Device | Profile | |
| Anders Mansson | Chief Officer | Profile | |
| Monica Wallter | Advisor | Profile | |
| Markus Thor | Head of Business Development | Profile |
About Lidds AB Management Performance
The success or failure of an entity such as Lidds AB often depends on how effective the management is. Lidds AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lidds management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lidds management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
LIDDS AB develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer NZ-DTX for lung cancer and solid tumors NZ-DOX for solid tumors NZ-IO, an antibody-based immunotherapy NZ-STING for immuno-oncology and NZ-BELINA for breast cancer. LIDDS AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
The data published in Lidds AB's official financial statements usually reflect Lidds AB's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lidds AB. For example, before you start analyzing numbers published by Lidds accountants, it's critical to develop an understanding of what Lidds AB's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Lidds AB's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lidds AB's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lidds AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lidds AB. Please utilize our Beneish M Score to check the likelihood of Lidds AB's management manipulating its earnings.
Lidds AB Workforce Analysis
Traditionally, organizations such as Lidds AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lidds AB within its industry.Lidds AB Manpower Efficiency
Return on Lidds AB Manpower
| Revenue Per Employee | 507.7K | |
| Revenue Per Executive | 161.5K | |
| Net Loss Per Employee | 5.3M | |
| Net Loss Per Executive | 1.7M | |
| Working Capital Per Employee | 1.4M | |
| Working Capital Per Executive | 454.5K |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lidds AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Lidds Stock analysis
When running Lidds AB's price analysis, check to measure Lidds AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lidds AB is operating at the current time. Most of Lidds AB's value examination focuses on studying past and present price action to predict the probability of Lidds AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lidds AB's price. Additionally, you may evaluate how the addition of Lidds AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |